Recent insights into the regulation of the growth plate

Journal of Molecular Endocrinology

Volumn 53, Issue 1, 2014, Pages

  Lui, Julian C ^a   Nilsson, Ola ^a,b   Baron, Jeffrey ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Growth hormone; IGF; Ignal transduction; Microarray; Skeletal

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; NATRIURETIC PEPTIDE TYPE C; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 2; GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BONE GROWTH; CHONDROGENESIS; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENETIC ASSOCIATION; GROWTH PLATE; GROWTH REGULATION; HUMAN; LOSS OF FUNCTION MUTATION; MICROARRAY ANALYSIS; MICRODISSECTION; POSTNATAL GROWTH; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUTATION; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CHONDROGENESIS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME-WIDE ASSOCIATION STUDY; GROWTH HORMONE; GROWTH PLATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUTATION; NATRIURETIC PEPTIDE, C-TYPE; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84940229452     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0022     Document Type: Article

References (83)

1. Abad V, Meyers JL, Weise M, Gafni RI, Barnes KM, Nilsson O, Bacher JD & Baron J 2002 The role of the resting zone in growth plate chondrogenesis. Endocrinology 143 1851-1857. (doi:10.1210/endo.143.5.8776)
2. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D et al. 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine 349 2211-2222. (doi:10.1056/NEJMoa010107)
3. Agoston H, Khan S, James CG, Gillespie JR, Serra R, Stanton LA & Beier F 2007 C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways. BMC Developmental Biology 7 18. (doi:10.1186/1471-213X-7-18)
4. Ahmed SF & Farquharson C 2010 The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. Journal of Endocrinology 206 249-259. (doi:10.1677/JOE-10-0045)
5. Baker J, Liu JP, Robertson EJ & Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 73-82. (doi:10.1016/0092-8674(93)90680-O)
6. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI et al. 2004 Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. American Journal of Human Genetics 75 27-34. (doi:10.1086/ 422013)
7. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS & Norstedt G 1989 Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. Journal of Endocrinology 122 651-656. (doi:10.1677/joe.0.1220651)
8. Chau M, Forcinito P, Andrade AC, Hegde A, Ahn S, Lui JC, Baron J & Nilsson O 2011 Organization of the Indian hedgehog parathyroid hormone-related protein system in the postnatal growth plate. Journal of Molecular Endocrinology 47 99-107. (doi:10.1530/JME-10-0177)
9. Chen L & Deng CX 2005 Roles of FGF signaling in skeletal development and human genetic diseases. Frontiers in Bioscience 10 1961-1976. (doi:10.2741/1671)
10. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, Yayon A & Deng CX 1999 Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. Journal of Clinical Investigation 104 1517-1525. (doi:10.1172/JCI6690)
11. Christiansen J, Kolte AM, Hansen T & Nielsen FC 2009 IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. Journal of Molecular Endocrinology 43 187-195. (doi:10.1677/JME-090016)
12. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y et al. 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide. PNAS 98 4016-4021. (doi:10.1073/pnas.071389098)
13. De Luca F, Barnes KM, Uyeda JA, De-Levi S, Abad V, Palese T, Mericq V & Baron J 2001 Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology 142 430-436. (doi:10.1210/ endo.142.1.7901)
14. Dobie R, MacRae V, Pass C, Jasim S, Ahmed F & Farquharson C 2013 Increased linear bone growth in SOCS2 knockout mice in response to GH is independent of systemic or local IGF1. Endocrine abstracts 31 P2. (doi:10.1530/endoabs.31.P2)
15. Emons J, Chagin AS, Hultenby K, Zhivotovsky B, Wit JM, Karperien M & Savendahl L 2009 Epiphyseal fusion in the human growth plate does not involve classical apoptosis. Pediatric Research 66 654-659. (doi:10.1203/PDR.0b013e3181beaa8c)
16. Eswarakumar VP & Schlessinger J 2007 Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. PNAS 104 3937-3942. (doi:10.1073/pnas.0700012104)
17. Fang P, Hi CY, Derr MA, Rosenfeld RG, Hwa V & Cowell CT 2012 Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R). Journal of Clinical Endocrinology and Metabolism 97 E243-E247. (doi:10.1210/jc.2011-2142)
18. Foldynova-Trantirkova S, Wilcox WR & Krejci P 2012 Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Human Mutation 33 29-41. (doi:10.1002/humu.21636)
19. Galman C, Lundasen T, Kharitonenkov A, Bina HA, Eriksson M, Hafstrom I, Dahlin M, Amark P, Angelin B & Rudling M 2008 The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARa activation in man. Cell Metabolism 8 169-174. (doi:10.1016/j.cmet.2008.06.014)
20. Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, Bonnafous S, Patouraux S, Tran A, Gual P, Le Marchand-Brustel Y et al. 2013 Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Science Translational Medicine 5 203ra124. (doi:10.1126/ scitranslmed.3006247)
21. Garcia-Aragon J, Lobie PE, Muscat GE, Gobius KS, Norstedt G & Waters MJ 1992 Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development 114 869-876.
22. Govoni KE, Lee SK, Chung YS, Behringer RR, Wergedal JE, Baylink DJ & Mohan S 2007 Disruption of insulin-like growth factor-I expression in type IIaI collagen-expressing cells reduces bone length and width in mice. Physiological Genomics 30 354-362. (doi:10.1152/physiolgenomics.00022.2007)
23. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S & Hirose S 1994 Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. Journal of Biological Chemistry 269 10729-10733.
24. Hannema SE, van Duyvenvoorde HA, Premsler T, Yang RB, Mueller TD, Gassner B, Oberwinkler H, Roelfsema F, Santen GW, Prickett T et al. 2013 An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. Journal of Clinical Endocrinology and Metabolism 98 E1988-E1998. (doi:10.1210/jc.2013-2358)
25. Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J & Nielsen FC 2004 Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Molecular and Cellular Biology 24 4448-4464. (doi:10. 1128/MCB.24.10.4448-4464.2004)
26. Hirai T, Chagin AS, Kobayashi T, Mackem S & Kronenberg HM 2011 Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life. PNAS 108 191-196. (doi:10.1073/pnas.1005011108)
27. Hung IH, Yu K, Lavine KJ & Ornitz DM 2007 FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Developmental Biology 307 300-313. (doi:10.1016/j.ydbio.2007.04.048)
28. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ & Kliewer SA 2008 Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism 8 77-83. (doi:10.1016/j.cmet. 2008.05.006)
29. Jacob AL, Smith C, Partanen J & Ornitz DM 2006 Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Developmental Biology 296 315-328. (doi:10.1016/j.ydbio.2006.05.031)
30. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA et al. 2005 FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation 115 1627-1635. (doi:10.1172/JCI23606)
31. Kobayashi T, Lyons KM, McMahon AP & Kronenberg HM 2005 BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. PNAS 102 18023-18027. (doi:10.1073/pnas. 0503617102)
32. Koziel L, Wuelling M, Schneider S & Vortkamp A 2005 Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 132 5249-5260. (doi:10.1242/dev.02097)
33. Krebs DL & Hilton DJ 2001 SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19 378-387. (doi:10.1634/stemcells. 19-5-378)
34. Krejci P, Krakow D, Mekikian PB & Wilcox WR 2007 Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatric Research 61 267-272. (doi:10.1203/pdr.0b013e318030d157)
35. Krejci P, Salazar L, Goodridge HS, Kashiwada TA, Schibler MJ, Jelinkova P, Thompson LM & Wilcox WR 2008 STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes. Journal of Cell Science 121 272-281. (doi:10.1242/jcs.017160)
36. Kronenberg HM 2003 Developmental regulation of the growth plate. Nature 423 332-336. (doi:10.1038/nature01657)
37. Kubicky RA, Wu S, Kharitonenkov A & De Luca F 2012 Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 153 2287-2295. (doi:10.1210/en.2011-1909)
38. Lango AH, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S et al. 2010 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467 832-838. (doi:10.1038/nature09410)
39. Laron Z, Lilos P & Klinger B 1993 Growth curves for Laron syndrome. Archives of Disease in Childhood 68 768-770. (doi:10.1136/adc.68.6.768)
40. Lazarus JE, Hegde A, Andrade AC, Nilsson O & Baron J 2007 Fibroblast growth factor expression in the postnatal growth plate. Bone 40 577-586. (doi:10.1016/j.bone.2006.10.013)
41. Li C, Chen L, Iwata T, Kitagawa M, Fu XY & Deng CX 1999 A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Human Molecular Genetics 8 35-44. (doi:10.1093/hmg/8.1.35)
42. Liu Z, Xu J, Colvin JS & Ornitz DM 2002 Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes and Development 16 859-869. (doi:10.1101/gad.965602)
43. Lorget F, Kaci N, Peng J, Benoist-Lasselin C, Mugniery E, Oppeneer T, Wendt DJ, Bell SM, Bullens S, Bunting S et al. 2012 Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. American Journal of Human Genetics 91 1108-1114. (doi:10.1016/j.ajhg.2012.10.014)
44. Lui JC, Andrade AC, Forcinito P, Hegde A, Chen W, Baron J & Nilsson O 2010 Spatial and temporal regulation of gene expression in the mammalian growth plate. Bone 46 1380-1390. (doi:10.1016/j.bone. 2010.01.373)
45. Lui JC, Nilsson O, Chan Y, Palmer CD, Andrade AC, Hirschhorn JN & Baron J 2012 Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height. Human Molecular Genetics 21 5193-5201. (doi:10.1093/hmg/dds347)
46. Lupu F, Terwilliger JD, Lee K, Segre GV & Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Developmental Biology 229 141-162. (doi:10.1006/dbio.2000.9975)
47. MacRae VE, Horvat S, Pells SC, Dale H, Collinson RS, Pitsillides AA, Ahmed SF & Farquharson C 2009 Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice. Journal of Cellular Physiology 21 8276-284. (doi:10.1002/jcp.21593)
48. Marchini A, Hacker B, Marttila T, Hesse V, Emons J, Weiss B, Karperien M & Rappold G 2007 BNP is a transcriptional target of the short stature homeobox gene SHOX. Human Molecular Genetics 16 3081-3087. (doi:10.1093/hmg/ddm266)
49. Matsushita T, Wilcox WR, Chan YY, Kawanami A, Bukulmez H, Balmes G, Krejci P, Mekikian PB, Otani K, Yamaura I et al. 2009 FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Human Molecular Genetics 18 227-240. (doi:10.1093/ hmg/ddn339)
50. Matsushita M, Kitoh H, Ohkawara B, Mishima K, Kaneko H, Ito M, Masuda A, Ishiguro N & Ohno K 2013 Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia. PLoS ONE 8 e81569. (doi:10.1371/ journal.pone.0081569)
51. Mericq V, Uyeda JA, Barnes KM, De Luca F & Baron J 2000 Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatric Research 47 189-193. (doi:10.1203/00006450-200002000-00007)
52. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ & Alexander WS 2000 Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405 1069-1073. (doi:10.1038/35016611)
53. Miura K, Namba N, Fujiwara M, Ohata Y, Ishida H, Kitaoka T, Kubota T, Hirai H, Higuchi C, Tsumaki N et al. 2012 An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene. PLoS ONE 7 e42180. (doi:10.1371/journal.pone.0042180)
54. Nilsson O, Parker EA, Hegde A, Chau M, Barnes KM & Baron J 2007 Gradients in bone morphogenetic protein-related gene expression across the growth plate. Journal of Endocrinology 193 75-84. (doi:10.1677/joe.1.07099)
55. Olney RC, Bukulmez H, Bartels CF, Prickett TC, Espiner EA, Potter LR & Warman ML 2006 Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. Journal of Clinical Endocrinology and Metabolism 91 1229-1232. (doi:10.1210/jc.2005-1949)
56. Ozasa A, Komatsu Y, Yasoda A, Miura M, Sakuma Y, Nakatsuru Y, Arai H, Itoh N & Nakao K 2005 Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36 1056-1064. (doi:10.1016/j.bone.2005.03.006)
57. Parker EA, Hegde A, Buckley M, Barnes KM, Baron J & Nilsson O 2007 Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. Journal of Endocrinology 194 31-40. (doi:10.1677/JOE-07-0012)
58. Pass C, MacRae VE, Huesa C, Faisal AS & Farquharson C 2012 SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis. Journal of Bone and Mineral Research 27 1055-1066. (doi:10.1002/jbmr.1544)
59. Pejchalova K, Krejci P & Wilcox WR 2007 C-natriuretic peptide: an important regulator of cartilage. Molecular Genetics and Metabolism 92 210-215. (doi:10.1016/j.ymgme.2007.06.014)
60. Potter LR, Abbey-Hosch S & Dickey DM 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews 27 47-72. (doi:10.1210/er.2005-0014)
61. Priore R, Dailey L & Basilico C 2006 Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. Journal of Cellular Physiology 207 800-808. (doi:10.1002/jcp.20620)
62. Retting KN, Song B, Yoon BS & Lyons KM 2009 BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136 1093-1104. (doi:10.1242/dev.029926)
63. Rosenfeld RG, Belgorosky A, Camacho-Hubner C, Savage MO, Wit JM & Hwa V 2007 Defects in growth hormone receptor signaling. Trends in Endocrinology and Metabolism 18 134-141. (doi:10.1016/j.tem.2007.03.004)
64. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le MM & Munnich A 1994 Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 252-254. (doi:10.1038/371252a0)
65. Shiang R, Thompson LM, Zhu YZ, Church DM, Fielder TJ, Bocian M, Winokur ST & Wasmuth JJ 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 335-342. (doi:10.1016/0092-8674(94)90302-6)
66. Shu B, Zhang M, Xie R, Wang M, Jin H, Hou W, Tang D, Harris SE, Mishina Y, O'Keefe RJ et al. 2011 BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. Journal of Cell Science 124 3428-3440. (doi:10.1242/jcs.083659)
67. Straus DS & Takemoto CD 1990 Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Molecular Endocrinology 4 91-100. (doi:10.1210/mend-4-1-91)
68. Suda K, Iguchi G, Yamamoto M, Handayaningsih AE, Nishizawa H, Takahashi M, Okimura Y, Kaji H, Chihara Y & Takahashi Y 2011 A case of gigantism associated with a missense mutation in the SOCS2 gene. Endocrine Society Annual Meeting 2011. OR36-1.
69. Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S & Imamura T 2008. Klotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Molecular Endocrinology 22 1006-1014. (doi:10.1210/me.2007-0313)
70. Tsuji T & Kunieda T 2005 A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse. Journal of Biological Chemistry 280 14288-14292. (doi:10.1074/jbc.C500024200)
71. Ulici V, James CG, Hoenselaar KD & Beier F 2010 Regulation of gene expression by PI3K in mouse growth plate chondrocytes. PLoS ONE 5 e8866. (doi:10.1371/journal.pone.0008866)
72. Vasques GA, Amano N, Docko AJ, Funari MF, Quedas EP, Nishi MY, Arnhold IJ, Hasegawa T & Jorge AA 2013 Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. Journal of Clinical Endocrinology and Metabolism 98 E1636-E1644. (doi:10.1210/jc.2013-2142)
73. Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL et al. 2011 Nosology and classification of genetic skeletal disorders: 2010 revision. American Journal of Medical Genetics. Part A 155A 943-968. (doi:10.1002/ajmg.a.33909)
74. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, Freathy RM, Perry JR, Stevens S, Hall AS et al. 2008 Genome-wide association analysis identifies 20 loci that influence adult height. Nature Genetics 40 575-583. (doi:10.1038/ng.121)
75. Wit JM & Camacho-Hubner C 2011 Endocrine regulation of longitudinal bone growth. Endocrine Development 21 30-41. (doi:10.1159/000328119)
76. Wit JM, Kamp GA & Rikken B 1996 Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatric Research 39 295-302. (doi:10.1203/00006450-199602000-00018)
77. Woo YC, Xu A, Wang Y & Lam KS 2013 Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clinical Endocrinology 78 489-496. (doi:10.1111/cen.12095)
78. Wu S, Levenson A, Kharitonenkov A & De Luca F 2012 Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. Journal of Biological Chemistry 287 26060-26067. (doi:10.1074/jbc.M112.343707)
79. Wu S, Grunwald T, Kharitonenkov A, Dam J, Jockers R & De Luca F 2013 Increased expression of fibroblast growth factor 21 (FGF21) during chronic undernutrition causes growth hormone insensitivity in chondrocytes by inducing leptin receptor overlapping transcript (LEPROT) and leptin receptor overlapping transcript-like 1 (LEPROTL1) expression. Journal of Biological Chemistry 288 27375-27383. (doi:10.1074/jbc.M113.462218)
80. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR et al. 2002 Circulating levels of IGF-1 directly regulate bone growth and density. Journal of Clinical Investigation 110 771-781. (doi:10.1172/JCI0215463)
81. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M et al. 2004 Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nature Medicine 10 80-86. (doi:10.1038/nm971)
82. Yoon BS, Pogue R, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR & Lyons KM 2006 BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 133 4667-4678. (doi:10.1242/dev.02680)
83. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA & Ornitz DM 2003 Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130 3063-3074. (doi:10.1242/dev.00491)